Uncommon Subtypes of Malignant Melanomas: A Review Based on Clinical and Molecular Perspectives
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Uncommon Subtypes of Malignant Melanomas: A Review Based on Clinical and Molecular Perspectives
Authors
Keywords
-
Journal
Cancers
Volume 12, Issue 9, Pages 2362
Publisher
MDPI AG
Online
2020-08-21
DOI
10.3390/cancers12092362
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The 2018 World Health Organization Classification of Cutaneous, Mucosal, and Uveal Melanoma: Detailed Analysis of 9 Distinct Subtypes Defined by Their Evolutionary Pathway
- (2020) David E. Elder et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- The TERT copy number gain is sensitive to telomerase inhibitors in human melanoma
- (2020) Jinyu Yu et al. CLINICAL SCIENCE
- Spitz melanoma is a distinct subset of spitzoid melanoma
- (2020) Shyam S. Raghavan et al. MODERN PATHOLOGY
- The Angiosarcoma Project: enabling genomic and clinical discoveries in a rare cancer through patient-partnered research
- (2020) Corrie A. Painter et al. NATURE MEDICINE
- Primary dermal melanoma: clinical behaviour, prognosis and treatment
- (2020) Christopher G. Harris et al. EJSO
- Overall survival and biomarker analysis of a phase Ib combination study of toripalimab, a humanized IgG4 mAb against programmed death-1 (PD-1) with axitinib in patients with metastatic mucosal melanoma.
- (2020) Xinan Sheng et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase II study of vorolanib (CM082) in combination with toripalimab (JS001) in patients with advanced mucosal melanoma.
- (2020) Lu Si et al. JOURNAL OF CLINICAL ONCOLOGY
- Preliminary activity of tipifarnib in tumors of the head and neck, salivary gland and urothelial tract with HRAS mutations.
- (2020) Alan Loh Ho et al. JOURNAL OF CLINICAL ONCOLOGY
- NOMINATOR: Feasibility of genomic testing of rare cancers to match cancer to treatment.
- (2020) Damien Kee et al. JOURNAL OF CLINICAL ONCOLOGY
- CheckMate 067: Long-term outcomes in patients with mucosal melanoma.
- (2020) Alexander Noor Shoushtari et al. JOURNAL OF CLINICAL ONCOLOGY
- Primary malignant melanoma of the lung: a case report and literature review
- (2020) Shuangshuang Deng et al. BMC Pulmonary Medicine
- Distinct Molecular Profiles and Immunotherapy Treatment Outcomes of V600E and V600K BRAF-Mutant Melanoma
- (2019) Inês Pires da Silva et al. CLINICAL CANCER RESEARCH
- Differential modulation and prognostic values of immune-escape genes in uveal melanoma
- (2019) Maria Sofia Basile et al. PLoS One
- Recurrent hotspot SF3B1 mutations at codon 625 in vulvovaginal mucosal melanoma identified in a study of 27 Australian mucosal melanomas
- (2019) Camelia Quek et al. Oncotarget
- Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
- (2019) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
- (2019) Brian I. Rini et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting the ERK Signaling Pathway in Melanoma
- (2019) Paola Savoia et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Treatment of melanoma of unknown primary in the era of immunotherapy and targeted therapy: A Dutch population‐based study
- (2019) D Verver et al. INTERNATIONAL JOURNAL OF CANCER
- Analysis of mucosal melanoma whole-genome landscapes reveals clinically relevant genomic aberrations
- (2019) Rong Zhou et al. CLINICAL CANCER RESEARCH
- Enhanced fatty acid scavenging and glycerophospholipid metabolism accompanies melanocyte neoplasia progression in zebrafish
- (2019) Fiona Henderson et al. CANCER RESEARCH
- Belvarafenib, a novel pan-RAF inhibitor, in solid tumor patients harboring BRAF, KRAS, or NRAS mutations: Phase I study.
- (2019) Tae Won Kim et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical mutational profiling and categorization of BRAF mutations in melanomas using next generation sequencing
- (2019) Parvez M. Lokhandwala et al. BMC CANCER
- Evaluation of the efficacy of immunotherapy for non-resectable mucosal melanoma
- (2019) Antoine Moya-Plana et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Frequency of mutations in BRAF, NRAS, and KIT in different populations and histological subtypes of melanoma
- (2019) Luz Dary Gutiérrez-Castañeda et al. MELANOMA RESEARCH
- The clinical characteristics of melanoma with BRAF V600R mutation
- (2019) Karen A. Malkhasyan et al. MELANOMA RESEARCH
- Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma
- (2019) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Phase Ib Study of Pembrolizumab as Second-Line Therapy for Chinese Patients With Advanced or Metastatic Melanoma (KEYNOTE-151)
- (2019) Lu Si et al. Translational Oncology
- Clinicopathological characteristics and survival of primary malignant melanoma of the esophagus
- (2019) Tadayoshi Hashimoto et al. Oncology Letters
- Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targets
- (2019) Felicity Newell et al. Nature Communications
- Uveal Melanoma, Angiogenesis and Immunotherapy, Is There Any Hope?
- (2019) Florian Castet et al. Cancers
- So Close, yet so Far: Discrepancies between Uveal and Other Melanomas. A Position Paper from UM Cure 2020
- (2019) Manuel Rodrigues et al. Cancers
- Atypical BRAF and NRAS Mutations in Mucosal Melanoma
- (2019) Nicolas Dumaz et al. Cancers
- Primary diffuse meningeal melanomatosis – a rare form of meningeal melanoma: case report
- (2019) Tomasz Garbacz et al. BMC Neurology
- Esophageal melanoma: a systematic review and exploratory recurrence and survival analysis
- (2019) D Schizas et al. DISEASES OF THE ESOPHAGUS
- Targeted Therapy in Advanced Melanoma With Rare BRAF Mutations
- (2019) Christian Menzer et al. JOURNAL OF CLINICAL ONCOLOGY
- The mutational landscape of mucosal melanoma
- (2019) Kelsey W. Nassar et al. SEMINARS IN CANCER BIOLOGY
- Patients with melanoma of unknown primary show better outcome under immune checkpoint inhibitor therapy than patients with known primary: preliminary results
- (2019) Thilo Gambichler et al. OncoImmunology
- Immunobiology of Uveal Melanoma: State of the Art and Therapeutic Targets
- (2019) Maria Sofia Basile et al. Frontiers in Oncology
- BRAF, KIT, and NRAS Mutations of Acral Melanoma in White Patients
- (2019) Emi Dika et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Primary and Metastatic Melanoma With NTRK Fusions
- (2018) Cecilia Lezcano et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Whole-exome sequencing of a meningeal melanocytic tumour reveals activating CYSLTR2 and EIF1AX hotspot mutations and similarities to uveal melanoma
- (2018) Heidi V. N. Küsters-Vandevelde et al. Brain Tumor Pathology
- Spitzoid melanoma with histopathologic features of ALK gene rearrangement exhibiting ALK copy number gain: A novel mechanism of ALK activation in spitzoid neoplasia
- (2018) M. Farah et al. BRITISH JOURNAL OF DERMATOLOGY
- MEK inhibition may increase survival of NRAS-mutated melanoma patients treated with checkpoint blockade: Results of a retrospective multicentre analysis of 364 patients
- (2018) Michael Constantin Kirchberger et al. EUROPEAN JOURNAL OF CANCER
- The Immune Landscape of Cancer
- (2018) Vésteinn Thorsson et al. IMMUNITY
- Selumetinib in Combination With Dacarbazine in Patients With Metastatic Uveal Melanoma: A Phase III, Multicenter, Randomized Trial (SUMIT)
- (2018) Richard D. Carvajal et al. JOURNAL OF CLINICAL ONCOLOGY
- Genetic Alterations in Primary Acral Melanoma and Acral Melanocytic Nevus in Korea: Common Mutated Genes Show Distinct Cytomorphological Features
- (2018) Ki Rang Moon et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- STAT3 Mediates Nilotinib Response in KIT-Altered Melanoma: A Phase II Multicenter Trial of the French Skin Cancer Network
- (2018) Julie Delyon et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Pembrolizumab for primary malignant melanoma of the central nervous system
- (2018) Chakib El Habnouni et al. JOURNAL OF NEURO-ONCOLOGY
- Whole-exome sequencing of oral mucosal melanoma reveals mutational profile and therapeutic targets
- (2018) Jiong Lyu et al. JOURNAL OF PATHOLOGY
- TERT copy gain predicts the outcome of high-dose interferon α-2b therapy in acral melanoma
- (2018) Sifan Yu et al. OncoTargets and Therapy
- Analysis of KIT gene mutations in patients with melanoma of the head and neck mucosa: a retrospective clinical report
- (2018) Ullyanov Bezerra Toscano de Mendonça et al. Oncotarget
- Antitumour activity of pembrolizumab in advanced mucosal melanoma: a post-hoc analysis of KEYNOTE-001, 002, 006
- (2018) Omid Hamid et al. BRITISH JOURNAL OF CANCER
- Redirected T cell lysis in patients with metastatic uveal melanoma with gp100-directed TCR IMCgp100: Overall survival findings.
- (2018) Takami Sato et al. JOURNAL OF CLINICAL ONCOLOGY
- High response rate to PD-1 blockade in desmoplastic melanomas
- (2018) Zeynep Eroglu et al. NATURE
- The Cancer Genome Atlas Project: An Integrated Molecular View of Uveal Melanoma
- (2018) Martine J. Jager et al. OPHTHALMOLOGY
- An approved in vitro approach to preclinical safety and efficacy evaluation of engineered T cell receptor anti-CD3 bispecific (ImmTAC) molecules
- (2018) Jane Harper et al. PLoS One
- Melanoma subtypes: Genomic profiles, prognostic molecular markers and therapeutic possibilities
- (2018) Roy Rabbie et al. JOURNAL OF PATHOLOGY
- Tumor mutational burden and response to PD-1 inhibitors in a case series of patients with metastatic desmoplastic melanoma
- (2018) Lise Boussemart et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Human tumor genomics and zebrafish modeling identify SPRED1 loss as a driver of mucosal melanoma
- (2018) Julien Ablain et al. SCIENCE
- Efficacy of Immunotherapy in Patients with Metastatic Mucosal or Uveal Melanoma
- (2018) Claire Mignard et al. Journal of Oncology
- Amelanotic Meningeal Melanoma with Leptomeningeal Dissemination: A Case Report and Systematic Literature Review
- (2018) Simin Zhang et al. World Neurosurgery
- PD-L1 expression in tumor metastasis is different between uveal melanoma and cutaneous melanoma
- (2017) Asad Javed et al. Immunotherapy
- Efficacy and Safety of Nivolumab Alone or in Combination With Ipilimumab in Patients With Mucosal Melanoma: A Pooled Analysis
- (2017) Sandra P. D’Angelo et al. JOURNAL OF CLINICAL ONCOLOGY
- Landscape of genomic alterations (GA) and tumor mutational burden (TMB) in different metastatic melanoma (MM) subtypes.
- (2017) Douglas Buckner Johnson et al. JOURNAL OF CLINICAL ONCOLOGY
- Mucosal melanoma: clinical, histological and c-kit gene mutational profile of 86 French cases
- (2017) E. Cinotti et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- The NF1 gene in tumor syndromes and melanoma
- (2017) Maija Kiuru et al. LABORATORY INVESTIGATION
- Melanoma subtypes demonstrate distinct PD-L1 expression profiles
- (2017) Genevieve J Kaunitz et al. LABORATORY INVESTIGATION
- Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study (KEYNOTE-006)
- (2017) Jacob Schachter et al. LANCET
- Binimetinib versus dacarbazine in patients with advanced NRAS -mutant melanoma (NEMO): a multicentre, open-label, randomised, phase 3 trial
- (2017) Reinhard Dummer et al. LANCET ONCOLOGY
- Whole-exome sequencing identifies recurrent SF3B1 R625 mutation and comutation of NF1 and KIT in mucosal melanoma
- (2017) Jennifer D. Hintzsche et al. MELANOMA RESEARCH
- Spitz nevi and Spitzoid melanomas: exome sequencing and comparison with conventional melanocytic nevi and melanomas
- (2017) Rossitza Lazova et al. MODERN PATHOLOGY
- NF1-mutated melanoma tumors harbor distinct clinical and biological characteristics
- (2017) Helena Cirenajwis et al. Molecular Oncology
- Whole-genome landscapes of major melanoma subtypes
- (2017) Nicholas K. Hayward et al. NATURE
- Primary central nervous system malignant melanoma with leptomeningeal melanomatosis: a case report and review of the literature
- (2017) Kentaro Fujimori et al. NEUROSURGICAL REVIEW
- Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma
- (2017) Georgina V. Long et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oncogenic BRAF fusions in mucosal melanomas activate the MAPK pathway and are sensitive to MEK/PI3K inhibition or MEK/CDK4/6 inhibition
- (2017) H S Kim et al. ONCOGENE
- BRAF, NRAS, KIT, TERT, GNAQ/GNA11 mutation profile analysis of head and neck mucosal melanomas: a study of 42 cases
- (2017) Şule Öztürk Sari et al. PATHOLOGY
- Dual MEK/AKT inhibition with trametinib and GSK2141795 does not yield clinical benefit in metastatic NRAS-mutant and wild-type melanoma
- (2017) Alain P. Algazi et al. Pigment Cell & Melanoma Research
- Kinase gene fusions in defined subsets of melanoma
- (2017) Jacqueline Turner et al. Pigment Cell & Melanoma Research
- Molecular genetic and immunotherapeutic targets in metastatic melanoma
- (2017) C. Melis et al. VIRCHOWS ARCHIV
- First-in-Class ERK1/2 Inhibitor Ulixertinib (BVD-523) in Patients with MAPK Mutant Advanced Solid Tumors: Results of a Phase I Dose-Escalation and Expansion Study
- (2017) Ryan J. Sullivan et al. Cancer Discovery
- Targeted next generation sequencing of mucosal melanomas identifies frequent NF1 and RAS mutations
- (2017) Ioana Cosgarea et al. Oncotarget
- Genetic and Genomic Characterization of 462 Melanoma Patient-Derived Xenografts, Tumor Biopsies, and Cell Lines
- (2017) Bradley Garman et al. Cell Reports
- Association of Incident Amelanotic Melanoma With Phenotypic Characteristics, MC1R Status, and Prior Amelanotic Melanoma
- (2017) Steven Vernali et al. JAMA Dermatology
- Mucosal Melanoma: A Clinically and Biologically Unique Disease Entity
- (2017) Richard D. Carvajal et al. Journal of the National Comprehensive Cancer Network
- Primary and Metastatic Cutaneous Melanomas Express ALK Through Alternative Transcriptional Initiation
- (2016) Klaus J. Busam et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Pimasertib (PIM) versus dacarbazine (DTIC) in patients (pts) with cutaneous NRAS melanoma: a controlled, open-label phase II trial with crossover
- (2016) C. Lebbe et al. ANNALS OF ONCOLOGY
- Primary Noncutaneous Malignant Melanoma of the Breast
- (2016) Mohammad Rassouli et al. Breast Journal
- The efficacy of anti-PD-1 agents in acral and mucosal melanoma
- (2016) Alexander N. Shoushtari et al. CANCER
- GNAQ and GNA11 mutations occur in 9.5% of mucosal melanoma and are associated with poor prognosis
- (2016) Xinan Sheng et al. EUROPEAN JOURNAL OF CANCER
- GermlineBAP1alterations in familial uveal melanoma
- (2016) Karan Rai et al. GENES CHROMOSOMES & CANCER
- NCCN Guidelines Insights: Melanoma, Version 3.2016
- (2016) Daniel G. Coit et al. Journal of the National Comprehensive Cancer Network
- Melanoma masquerading as nonmelanocytic lesions
- (2016) Audrey Detrixhe et al. MELANOMA RESEARCH
- Recurrent activating mutations of G-protein-coupled receptor CYSLTR2 in uveal melanoma
- (2016) Amanda R Moore et al. NATURE GENETICS
- Prognosis of Mucosal, Uveal, Acral, Nonacral Cutaneous, and Unknown Primary Melanoma From the Time of First Metastasis
- (2016) Deborah Kuk et al. ONCOLOGIST
- Uveal Melanomas with SF3B1 Mutations
- (2016) Serdar Yavuzyigitoglu et al. OPHTHALMOLOGY
- Characteristics and Surgical Outcomes for Primary Malignant Melanoma of the Esophagus
- (2016) Shugeng Gao et al. Scientific Reports
- Driver Mutations in Uveal Melanoma
- (2016) Christina L. Decatur et al. JAMA Ophthalmology
- 18F-FDG PET/CT and Melanoma: Staging, Immune Modulation and Mutation-Targeted Therapy Assessment, and Prognosis
- (2015) Powell Perng et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- NF1 Mutations Are Common in Desmoplastic Melanoma
- (2015) Thomas Wiesner et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Primary dermal melanoma: a West Australian cohort
- (2015) James Teow et al. ANZ JOURNAL OF SURGERY
- Genomic Classification of Cutaneous Melanoma
- (2015) Rehan Akbani et al. CELL
- Phase II Study of Nilotinib in Melanoma Harboring KIT Alterations Following Progression to Prior KIT Inhibition
- (2015) R. D. Carvajal et al. CLINICAL CANCER RESEARCH
- VEGF-A modulates expression of inhibitory checkpoints on CD8+T cells in tumors
- (2015) Thibault Voron et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Mutation scanning ofBRAF,NRAS,KIT,andGNAQ/GNA11in oral mucosal melanoma: a study of 57 cases
- (2015) Jiong Lyu et al. JOURNAL OF ORAL PATHOLOGY & MEDICINE
- Metastatic melanomas of unknown primary show better prognosis than those of known primary: A systematic review and meta-analysis of observational studies
- (2015) Jung Min Bae et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial
- (2015) Alexander M M Eggermont et al. LANCET ONCOLOGY
- A phase 2 study of tremelimumab in patients with advanced uveal melanoma
- (2015) Anthony M. Joshua et al. MELANOMA RESEARCH
- Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathway
- (2015) A Hunter Shain et al. NATURE GENETICS
- Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
- (2015) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical Activity of Ipilimumab in Acral Melanoma: A Retrospective Review
- (2015) D. B. Johnson et al. ONCOLOGIST
- Phase II Trial of Nilotinib in Patients With Metastatic Malignant Melanoma Harboring KIT Gene Aberration: A Multicenter Trial of Korean Cancer Study Group (UN10-06)
- (2015) S. J. Lee et al. ONCOLOGIST
- Phase II DeCOG-Study of Ipilimumab in Pretreated and Treatment-Naïve Patients with Metastatic Uveal Melanoma
- (2015) Lisa Zimmer et al. PLoS One
- Impact of NRAS Mutations for Patients with Advanced Melanoma Treated with Immune Therapies
- (2015) D. B. Johnson et al. Cancer Immunology Research
- Molecular Characterization and Patient Outcome of Melanoma Nodal Metastases and an Unknown Primary Site
- (2014) Aleksandra Gos et al. ANNALS OF SURGICAL ONCOLOGY
- Hippo-Independent Activation of YAP by the GNAQ Uveal Melanoma Oncogene through a Trio-Regulated Rho GTPase Signaling Circuitry
- (2014) Xiaodong Feng et al. CANCER CELL
- Effect of Selumetinib vs Chemotherapy on Progression-Free Survival in Uveal Melanoma
- (2014) Richard D. Carvajal et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Update on primary mucosal melanoma
- (2014) Joselin D. Tacastacas et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Atypical Spitz tumours and sentinel lymph node biopsy: a systematic review
- (2014) Aimilios Lallas et al. LANCET ONCOLOGY
- Combined BRAF and MEK Inhibition versus BRAF Inhibition Alone in Melanoma
- (2014) Georgina V. Long et al. NEW ENGLAND JOURNAL OF MEDICINE
- Primary malignant melanoma of the breast: A case report and review of the literature
- (2014) YUJUN HE et al. Oncology Letters
- Kinase fusions are frequent in Spitz tumours and spitzoid melanomas
- (2014) Thomas Wiesner et al. Nature Communications
- Comparison of Clinicopathologic Features and Survival of Histopathologically Amelanotic and Pigmented Melanomas
- (2014) Nancy E. Thomas et al. JAMA Dermatology
- SOX10 Expression Distinguishes Desmoplastic Melanoma From Its Histologic Mimics
- (2013) Beth Palla et al. AMERICAN JOURNAL OF DERMATOPATHOLOGY
- Clinical activity of ipilimumab for metastatic uveal melanoma
- (2013) Jason J. Luke et al. CANCER
- Phase II Randomized Trial Comparing High-Dose IFN- 2b with Temozolomide Plus Cisplatin as Systemic Adjuvant Therapy for Resected Mucosal Melanoma
- (2013) B. Lian et al. CLINICAL CANCER RESEARCH
- Characterization of KIT mutation in melanoma
- (2013) Chi-Yuan Tzen et al. Dermatologica Sinica
- Efficacy and safety of ipilimumab 3mg/kg in patients with pretreated, metastatic, mucosal melanoma
- (2013) Michele Del Vecchio et al. EUROPEAN JOURNAL OF CANCER
- Imatinib for Melanomas Harboring Mutationally Activated or Amplified KIT Arising on Mucosal, Acral, and Chronically Sun-Damaged Skin
- (2013) F. Stephen Hodi et al. JOURNAL OF CLINICAL ONCOLOGY
- Phenotypic Characterization of Nevus and Tumor Patterns in MITF E318K Mutation Carrier Melanoma Patients
- (2013) Richard A. Sturm et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Genome sequencing of mucosal melanomas reveals that they are driven by distinct mechanisms from cutaneous melanoma
- (2013) Simon J Furney et al. JOURNAL OF PATHOLOGY
- The Liverpool uveal melanoma liver metastases pathway: Outcome following liver resection
- (2013) D. Gomez et al. JOURNAL OF SURGICAL ONCOLOGY
- MEK162 for patients with advanced melanoma harbouring NRAS or Val600 BRAF mutations: a non-randomised, open-label phase 2 study
- (2013) Paolo A Ascierto et al. LANCET ONCOLOGY
- Characteristics and survival of patients with invasive amelanotic melanoma in the USA
- (2013) Jacqueline F. Moreau et al. MELANOMA RESEARCH
- BRAF and KIT somatic mutations are present in amelanotic melanoma
- (2013) Daniela Massi et al. MELANOMA RESEARCH
- Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3
- (2013) Marcel Martin et al. NATURE GENETICS
- Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma
- (2013) J William Harbour et al. NATURE GENETICS
- Combined PKC and MEK inhibition in uveal melanoma with GNAQ and GNA11 mutations
- (2013) X Chen et al. ONCOGENE
- Ipilimumab for Patients With Advanced Mucosal Melanoma
- (2013) M. A. Postow et al. ONCOLOGIST
- Identification of anaplastic lymphoma kinase break points and oncogenic mutation profiles in acral/mucosal melanomas
- (2013) Hai-Tao Niu et al. Pigment Cell & Melanoma Research
- SF3B1 Mutations Are Associated with Alternative Splicing in Uveal Melanoma
- (2013) S. J. Furney et al. Cancer Discovery
- Assessment of association between BRAF-V600E mutation status in melanomas and clinical response to ipilimumab
- (2012) Vafa Shahabi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Uveal melanoma
- (2012) Francesco Spagnolo et al. CANCER TREATMENT REVIEWS
- Sunitinib Therapy for Melanoma Patients withKITMutations
- (2012) David R. Minor et al. CLINICAL CANCER RESEARCH
- Distinguishing Clinicopathologic Features of Patients with V600E and V600K BRAF-Mutant Metastatic Melanoma
- (2012) A. M. Menzies et al. CLINICAL CANCER RESEARCH
- BRAF inhibitor activity in V600R metastatic melanoma
- (2012) Oliver Klein et al. EUROPEAN JOURNAL OF CANCER
- Amelanotic melanomas presenting as red skin lesions: a diagnostic challenge with potentially lethal consequences
- (2012) Susannah E. McClain et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Iris melanoma: Features and prognosis in 317 children and adults
- (2012) Carol L. Shields et al. JOURNAL OF AAPOS
- Desmoplastic melanoma: A review
- (2012) Lucy L. Chen et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Activity of the oral MEK inhibitor trametinib in patients with advanced melanoma: a phase 1 dose-escalation trial
- (2012) Gerald S Falchook et al. LANCET ONCOLOGY
- The role of 8q24 copy number gains and c-MYC expression in amelanotic cutaneous melanoma
- (2012) Pedram Pouryazdanparast et al. MODERN PATHOLOGY
- Detection and Time to Treatment of Uveal Melanoma in the United Kingdom: An Evaluation of 2384 Patients
- (2012) Erika M. Damato et al. OPHTHALMOLOGY
- The genetics of uveal melanoma: an emerging framework for targeted therapy
- (2012) J. William Harbour Pigment Cell & Melanoma Research
- Sphincter-sparing local excision and hypofractionated radiation therapy for anorectal melanoma
- (2011) Patrick Kelly et al. CANCER
- NRAS mutation status is an independent prognostic factor in metastatic melanoma
- (2011) John A. Jakob et al. CANCER
- KIT Pathway Alterations in Mucosal Melanomas of the Vulva and Other Sites
- (2011) K. Omholt et al. CLINICAL CANCER RESEARCH
- Phase II, Open-Label, Randomized Trial of the MEK1/2 Inhibitor Selumetinib as Monotherapy versus Temozolomide in Patients with Advanced Melanoma
- (2011) J. M. Kirkwood et al. CLINICAL CANCER RESEARCH
- Nilotinib in patients with metastatic melanoma harboring KIT gene aberration
- (2011) Jin Hyun Cho et al. INVESTIGATIONAL NEW DRUGS
- KIT as a Therapeutic Target in Metastatic Melanoma
- (2011) Richard D. Carvajal JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Phase II, Open-Label, Single-Arm Trial of Imatinib Mesylate in Patients With Metastatic Melanoma Harboringc-KitMutation or Amplification
- (2011) Jun Guo et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic and Clinicopathologic Associations of OncogenicBRAFin Metastatic Melanoma
- (2011) Georgina V. Long et al. JOURNAL OF CLINICAL ONCOLOGY
- Amelanotic melanoma: a detailed morphologic analysis with clinicopathologic correlation of 75 cases
- (2011) Wang L. Cheung et al. JOURNAL OF CUTANEOUS PATHOLOGY
- Clinical outcome and pathological features associated with NRAS mutation in cutaneous melanoma
- (2011) Bianca Devitt et al. Pigment Cell & Melanoma Research
- Utility of Lymph Node Assessment for Atypical Spitzoid Melanocytic Neoplasms
- (2010) Bahair Ghazi et al. ANNALS OF SURGICAL ONCOLOGY
- Targeting KIT in melanoma: A paradigm of molecular medicine and targeted therapeutics
- (2010) Scott E. Woodman et al. BIOCHEMICAL PHARMACOLOGY
- Mutations inGNA11in Uveal Melanoma
- (2010) Catherine D. Van Raamsdonk et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mutations in KIT occur at low frequency in melanomas arising from anatomical sites associated with chronic and intermittent sun exposure
- (2010) Despina Handolias et al. Pigment Cell & Melanoma Research
- Frequent Mutation of BAP1 in Metastasizing Uveal Melanomas
- (2010) J. W. Harbour et al. SCIENCE
- CDKN2A and MC1R analysis in amelanotic and pigmented melanoma
- (2009) Paola Ghiorzo et al. MELANOMA RESEARCH
- Primary Dermal Melanoma
- (2008) David S. Cassarino et al. ARCHIVES OF DERMATOLOGY
- Phase II trial of imatinib mesylate in patients with metastatic melanoma
- (2008) K B Kim et al. BRITISH JOURNAL OF CANCER
- KIT Gene Mutations and Copy Number in Melanoma Subtypes
- (2008) C. Beadling et al. CLINICAL CANCER RESEARCH
- “White” Nevi and “Red” Melanomas: Association with the RHC Phenotype of the MC1R Gene
- (2008) Iris Zalaudek et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi
- (2008) Catherine D. Van Raamsdonk et al. NATURE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now